Why GLP‑1 parenteral manufacturing needs speed, compliance, flexibility - and a proven partner
GLP‑1 therapies are shaping the market like few other segments today. For manufacturers, this creates a rare opportunity: sterile high‑volume production of syringes and cartridges can now be scaled faster and more safely than ever before with modern, Annex 1‑aligned processes.
Companies that combine high‑throughput aseptic performance, digital batch release with PAS‑X MES, and flexible line concepts gain critical speed, ensure consistent product quality, and remain adaptable as device formats evolve.
This is exactly where Körber comes in. As an experienced GLP‑1 partner, we support you with an integrated approach that connects filling, inspection, packaging, handling, and digitalization. The result is an end‑to‑end process that enables speed, embeds compliance from the start, preserves flexibility, and significantly reduces operational and regulatory risks.
Experience from real GLP‑1 projects shows that right‑first‑time is not an aspiration but an achievable standard – provided processes are designed to be reliably replicated across sites while supporting sustainable long‑term growth. This is exactly what Körber stands for.
